Non-Alcoholic Fatty Liver Disease (NAFLD) Treatment in Moradabad - Dr. Pabitra Sahu (Gastroenterology & Hepatology) at Jigyasa Hospital
Who Is Dr. Pabitra Sahu?
Dr. Pabitra Sahu is a specialist in Gastroenterology and Hepatology at Jigyasa Hospital, Moradabad, providing detailed evaluation, staging, and long-term management for non-alcoholic fatty liver disease. He helps patients understand whether fatty liver is limited to simple fat accumulation or has progressed to inflammation, fibrosis, or cirrhosis.
His approach combines liver function testing, metabolic screening, ultrasound assessment, fibrosis evaluation when needed, and sustainable lifestyle guidance. Patients from Moradabad, Rampur, Sambhal, Amroha, and Bijnor access specialist fatty liver care with NABL-accredited diagnostic support.
Understanding Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease, commonly called NAFLD, has become one of the most common liver conditions diagnosed today. It is frequently discovered incidentally during a routine ultrasound or blood test rather than through obvious symptoms. Closely tied to rising rates of obesity, diabetes, and sedentary lifestyles, NAFLD represents a spectrum of liver changes that is often preventable and, in earlier stages, reversible with the right approach.
At Jigyasa Hospital, Moradabad, Dr. Pabitra Sahu provides thorough evaluation, staging, and long-term management of NAFLD, supported by a NABL-accredited diagnostic laboratory. The hospital is located on Rampur Road, Near Miglani Cinema, Moradabad 244001, and serves patients from Moradabad, Rampur, Sambhal, Amroha, Bijnor, and nearby areas.
What Is Non-Alcoholic Fatty Liver Disease?
NAFLD refers to the accumulation of excess fat within liver cells in individuals who do not consume alcohol at levels significant enough to explain this fat accumulation on its own. It is strongly linked to metabolic factors, particularly obesity, insulin resistance, type 2 diabetes, and abnormal cholesterol or triglyceride levels.
These risk factors often occur together as part of metabolic syndrome. Although fatty liver may begin silently, identifying and addressing it early can help prevent progression to more serious liver damage.
The Spectrum of NAFLD
NAFLD is not a single, uniform condition. It exists along a spectrum of severity, and understanding the stage is central to prognosis and the specific management approach recommended.
1. Simple Fatty Liver (Steatosis)
This is the earliest and most common stage, involving fat accumulation within liver cells without significant inflammation or damage. Many patients have no symptoms, and this stage generally has a lower risk of progressing to serious liver disease, though it still requires lifestyle intervention.
2. Non-Alcoholic Steatohepatitis (NASH)
When fat accumulation is accompanied by inflammation and liver cell damage, the condition progresses to NASH. This is more concerning because ongoing inflammation can lead to progressive scarring, known as fibrosis, over time.
3. Fibrosis
With continued inflammation, scar tissue begins to develop within the liver. Fibrosis is staged based on severity, and this staging is important for understanding prognosis and guiding treatment intensity.
4. Cirrhosis
In advanced, long-standing cases, fibrosis can progress to cirrhosis, representing the most advanced and largely irreversible stage of NAFLD-related liver damage.
Understanding Fatty Liver Grades
Patients are often told their fatty liver is Grade 1, Grade 2, or Grade 3 based on ultrasound findings. These grades reflect the degree of fat accumulation visible on imaging.
- Grade 1 (Mild): Mild fat accumulation, often an early finding.
- Grade 2 (Moderate): More significant fat accumulation.
- Grade 3 (Severe): Extensive fat accumulation.
- Ultrasound grading reflects fat amount but does not fully show inflammation or fibrosis.
Additional evaluation may therefore be needed to get a complete picture, particularly for patients with higher-grade findings or other risk factors.
Risk Factors for NAFLD
- Obesity, particularly abdominal obesity.
- Type 2 diabetes or insulin resistance.
- High triglyceride levels.
- Metabolic syndrome.
- Rapid weight loss in some cases.
- Certain medications.
- Polycystic ovary syndrome (PCOS).
- Sleep apnea.
- Genetic predisposition and individual susceptibility.
Symptoms of NAFLD
Most patients with simple fatty liver experience no symptoms at all, which is why the condition is frequently discovered incidentally during ultrasound or routine liver tests.
- Fatigue.
- Mild discomfort in the upper right abdomen.
- In advanced stages, symptoms consistent with cirrhosis may occur.
Specialist NAFLD Evaluation
Dr. Pabitra Sahu provides accurate staging and individualized, evidence-based management for fatty liver disease, from early steatosis to NASH, fibrosis, and cirrhosis.
Complete Metabolic Assessment
Evaluation includes liver function tests, blood sugar, HbA1c, lipid profile, viral hepatitis screening, and assessment of metabolic risk factors that commonly contribute to NAFLD.
Non-Invasive Disease Staging
Abdominal ultrasound helps identify fatty liver changes, while elastography or FibroScan may help estimate fibrosis severity without requiring a liver biopsy in many cases.
Long-Term Lifestyle and Liver Support
Treatment focuses on sustainable weight management, balanced nutrition, physical activity, metabolic condition control, and regular monitoring to track improvement over time.
Trusted Fatty Liver Care in Moradabad
Patients from Moradabad, Rampur, Sambhal, Amroha, Bijnor, and nearby districts choose Jigyasa Hospital for specialist NAFLD care, NABL-accredited testing, in-house ultrasound, and Ayushman Bharat empanelment.
Diagnosis of NAFLD at Jigyasa Hospital
Accurate diagnosis involves detecting fatty liver, excluding alternative causes, and assessing whether inflammation or fibrosis is present.
1. Initial Detection
NAFLD is often identified incidentally through routine abdominal ultrasound or mildly elevated liver enzymes on blood testing.
2. Confirming the Diagnosis and Excluding Other Causes
- Detailed history, including alcohol consumption patterns.
- Liver function tests to assess enzyme elevation.
- Metabolic screening, including blood sugar, HbA1c, and lipid profile.
- Viral hepatitis screening to rule out coexisting causes.
3. Staging Disease Severity
- Abdominal ultrasound for initial grading of fat accumulation.
- FibroScan or elastography to estimate liver stiffness and fibrosis.
- Liver biopsy in select cases where more precise staging is required or diagnosis remains uncertain.
Treatment Approach for NAFLD
Treatment is individualized according to disease severity, metabolic risk factors, and overall health. Sustainable lifestyle changes remain the foundation of effective fatty liver management.
1. Weight Management: The Cornerstone of Treatment
Gradual, sustained weight loss is the most effective intervention for NAFLD. Even a modest reduction of around 5-10% of body weight can improve liver fat and may improve inflammation and fibrosis in some patients.
- Reduced calorie intake with fewer refined sugars and processed foods.
- Greater focus on whole foods and balanced meals.
- Regular aerobic exercise and resistance training.
- Gradual approaches rather than rapid, extreme weight loss methods.
2. Managing Underlying Metabolic Conditions
Effective management of diabetes, high triglycerides, cholesterol abnormalities, and other components of metabolic syndrome is an important part of comprehensive NAFLD treatment.
3. Dietary Approach
- Reducing refined carbohydrates and added sugars, especially fructose-containing beverages.
- Limiting saturated and trans fats.
- Increasing fiber-rich foods, vegetables, and healthy fats.
- Moderating calorie intake in line with weight-management goals.
4. Physical Activity
Regular exercise can reduce liver fat content independent of weight loss, making it valuable even before significant weight change occurs.
5. Medication in Select Cases
Lifestyle modification remains the primary treatment. Certain medications may be considered in selected patients, particularly those with NASH and fibrosis or coexisting diabetes, based on individualized specialist assessment.
6. Avoiding Liver-Harming Substances
- Avoid alcohol, which can compound existing liver damage.
- Avoid unnecessary or unregulated supplements that may add strain to the liver.
7. Regular Monitoring
Periodic liver function tests and, when needed, repeat elastography or imaging help track progression or improvement and allow timely adjustment of the treatment plan.
Why Early Intervention Matters
Because simple fatty liver often has no symptoms, many patients do not realize the importance of addressing it until it is found incidentally. However, this early stage provides the best opportunity for meaningful reversal through lifestyle changes, before progression to NASH, fibrosis, or cirrhosis.
NAFLD is therefore one of the clearest examples in hepatology where early, proactive lifestyle intervention can meaningfully alter the long-term disease trajectory.
NAFLD and Cardiovascular Risk
NAFLD is not only a liver concern. It is also associated with increased cardiovascular risk because of its close relationship with metabolic syndrome. Managing fatty liver often supports better overall metabolic health, not only liver health.
Why Choose Jigyasa Hospital for NAFLD Care?
Fatty liver disease requires accurate staging, sustainable treatment planning, and long-term monitoring. Jigyasa Hospital, located on Rampur Road near Miglani Cinema, Moradabad, offers comprehensive NAFLD care under Dr. Pabitra Sahu.
- Specialist expertise in Gastroenterology and Hepatology for accurate staging and treatment planning.
- NABL-accredited laboratory for liver function and metabolic testing.
- In-house ultrasound for initial detection and fatty liver grading.
- Long-term monitoring to track improvement or disease progression.
- Ayushman Bharat PM-JAY empanelment for eligible patients.
- Regional access for patients from Moradabad, Rampur, Sambhal, Amroha, and Bijnor.
Book an Appointment with Dr. Pabitra Sahu
Jigyasa Hospital offers specialist evaluation and long-term management for non-alcoholic fatty liver disease under the guidance of Dr. Pabitra Sahu. Early assessment and sustainable lifestyle support can help reduce liver fat, prevent progression, and protect long-term health.
Near Miglani Cinema, Rampur Road, Moradabad 244001
Call Now
7900903333Frequently Asked Questions
Can fatty liver disease be completely reversed?
Yes, particularly in the earlier stage of simple fatty liver, sustained weight loss and lifestyle changes can significantly reduce or resolve liver fat accumulation. Even in more advanced NASH with some fibrosis, meaningful improvement is often possible with dedicated lifestyle intervention.
What does Grade 2 fatty liver mean, and is it serious?
This reflects a moderate degree of fat accumulation seen on ultrasound. While not immediately dangerous on its own, it warrants proper evaluation and lifestyle intervention to prevent progression, and further testing may be recommended to assess for associated inflammation or fibrosis.
How much weight do I need to lose to improve fatty liver?
Research suggests that even a modest weight loss of around 5-10% of body weight can meaningfully improve liver fat content, with greater improvements often seen with more substantial, sustained weight loss.
Can thin or normal-weight people get fatty liver disease?
Yes, while NAFLD is more common in individuals who are overweight or obese, it can also occur in normal-weight individuals, particularly those with other metabolic risk factors like insulin resistance or unfavorable body fat distribution.
What is the difference between NAFLD and NASH?
NAFLD is the broader term encompassing fat accumulation in the liver, while NASH specifically refers to the presence of inflammation and liver cell damage alongside fat accumulation, representing a more advanced and concerning stage within the NAFLD spectrum.
Do I need a liver biopsy if I have fatty liver disease?
Not always. Non-invasive tools like elastography (FibroScan) can often provide sufficient information about fibrosis severity. Biopsy is generally reserved for cases where these results are inconclusive or when more precise staging is specifically needed.
Is medication available to treat fatty liver disease?
While lifestyle modification remains the primary and most effective treatment, certain medications may be considered in specific situations, particularly for more advanced disease or coexisting conditions like diabetes, based on individualized specialist assessment.
Does fatty liver disease increase my risk of other health problems?
Yes, beyond liver-specific risks, NAFLD is associated with increased cardiovascular risk given its close relationship with metabolic syndrome, making comprehensive management valuable for overall health, not just liver health alone.
Why Patients Choose Us
- 24/7 Emergency & Trauma Care
- Top Specialist Doctors
- Modern ICU & Operation Theatres
- Transparent & Affordable Pricing
- Ayushman Bharat Empanelled
- Cashless Insurance Support
- Multispeciality Under One Roof
Our Location
Near Miglani Cinema,
Rampur Road,
Moradabad 244001